Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

How to Apply for the Accretion Nutraveda Limited IPO: Step-by-Step Investment Guide

 

Accretion Nutraveda Limited is a healthcare-focused manufacturing company engaged in the production of ayurvedic and nutraceutical products across various dosage forms, including tablets, capsules, liquids, powders, oils, and external applications. Operating as a Contract Development and Manufacturing Organisation (CDMO), the company serves clients in domestic and select international markets. Its product portfolio covers multiple healthcare categories such as liver care, women’s health, bone and joint care, digestive care, respiratory care, cognitive support, paediatric nutrition, and skin and hair care. The company operates from a GMP-compliant manufacturing facility in Gujarat, supported by recognised quality and safety certifications, which enables it to undertake regulated manufacturing for different client requirements.

To apply for the Accretion Nutraveda IPO, an investor needs an active Demat account, a trading account, and a bank account linked for online payments. The application can be submitted through the ASBA facility available on net banking platforms or via supported online trading applications. After selecting the IPO, investors need to enter the bid details and confirm the application. The amount remains blocked until the allotment process is completed, after which shares are credited to the Demat account if allotted.

For more details, visit the Accretion Nutraveda Limited IPO page.

Accretion Nutraveda Limited IPO Details and Objectives

Details

Information

IPO Date

January 27, 2026 to January 30, 2026

Issue Size

19,20,000 shares (agg. up to ₹25 Cr)

Price Band

₹122 to ₹129 per share

Lot Size

1000 shares

Listing At

BSE SME

Purpose of the IPO

  • Purchase of machineries for automation in company’s existing manufacturing unit

  • Purchase of machineries for a new manufacturing setup

  • Funding working capital requirements of the company

  • General corporate purposes

Timeline of Accretion Nutraveda Limited IPO

Event

Date

IPO Open Date

Tue, Jan 27, 2026

IPO Close Date

Fri, Jan 30, 2026

Tentative Allotment

Mon, Feb 2, 2026

Initiation of Refunds

Tue, Feb 3, 2026

Credit of Shares to Demat

Tue, Feb 3, 2026

Tentative Listing Date

Wed, Feb 4, 2026

Cut-off time for UPI mandate confirmation

5 PM on Fri, Jan 30, 2026

Pricing & Lot Size of Accretion Nutraveda Limited IPO

Price Band for the IPO

  • ₹122 to ₹129 per share

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Individual investors (Retail) (Min)

2

2,000

₹2,58,000

Individual investors (Retail) (Max)

2

2,000

₹2,58,000

S-HNI (Min)

3

3,000

₹3,87,000

S-HNI (Max)

7

7,000

₹9,03,000

B-HNI (Min)

8

8,000

₹10,32,000

Accretion Nutraveda Limited IPO Application Process

The Accretion Nutraveda Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:

Step 1: Login to Your Trading Platform

Access your trading account using the broker's app or website.

Step 2: Navigate to the IPO Section

Go to the IPO section to view active IPO listings.

Step 3: Select the Open IPO and Click Apply

Locate Accretion Nutraveda Limited IPO in the list of available IPOs and click the ‘Apply’ button.

Step 4: Enter the Quantity of Shares You Wish to Apply For

Specify the number of shares (lot size: 1000 shares) within the price band of ₹122 to ₹129 per share.

Step 5: Provide Your UPI ID

Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.

Step 6: Confirm the Application

Review your application details and confirm the UPI mandate before 5 PM on the last application day.

Step 7: Complete the Process and Wait for Allotment

Submit the application and monitor the allotment status to check if shares have been allocated to you.

Shares Offered in Accretion Nutraveda IPO

The allocation of shares in the Accretion Nutraveda IPO is structured across investor categories in line with applicable regulatory requirements. The issue provides defined reservations for qualified institutional buyers, non-institutional investors, and retail individual investors, with each category allotted a specified proportion of the net issue. This allocation framework outlines how the shares offered are distributed among different classes of investors.

Investor Category

Shares Offered

Market Maker Shares Offered

96,000 (5.00%)

QIB Shares Offered

9,08,000 (47.29%)

NII (HNI) Shares Offered

2,76,000 (14.37%)

Retail Shares Offered

6,40,000 (33.33%)

Total Shares Offered

19,20,000 (100.00%)

This reservation structure reflects the categorisation and allocation approach disclosed for the issue, indicating the proportion of shares available to each investor segment.

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹4.06 crore in FY23 to ₹10.86 crore as of March 2025.

  • Total income: Reached ₹16.06 crore in March 2025, as compared to ₹3.07 crore in FY23.

  • Profit After Tax (PAT): Stood at ₹2.61 crore for March 2025 as compared to ₹0.28 crore in FY23.

  • Net Worth: Recorded at ₹5.35 crore in March 2025 in comparison to ₹0.26 crore in FY23.

  • Reserves and surplus: Stood at ₹4.86 crore in March 2025, as compared to ₹-0.10 crore in FY23.

  • EBITDA: Stood at ₹3.65 crore in March 2025 in comparison to ₹0.59 crore in FY23.

Recent Performance and Growth Prospects

  • The company has expanded its asset base over recent financial periods, reflecting a broader operational scale and increased business activity.

  • Income levels have shown steady improvement, indicating higher business volumes and wider client engagement across its manufacturing services.

  • Profitability has strengthened compared to earlier years, supported by improved utilisation of manufacturing capacity and operational efficiencies.

  • The company’s net worth has increased, mainly due to retained earnings and internal accruals generated from business operations.

  • Reserves and surplus have moved to a positive position, reflecting improved financial stability and better capital retention.

  • Operating performance has improved in line with higher production and sales activity, contributing to better cost absorption.

  • The overall financial trend indicates gradual strengthening of the balance sheet and operating profile, supported by expansion in manufacturing activities and client servicing.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • The company operates largely as a contract manufacturer, which may result in dependence on client orders and continued business relationships for revenue visibility.

  • Operations are concentrated in a single manufacturing facility, which may expose the business to operational disruptions arising from regulatory, logistical, or facility-related issues.

Opportunities and Growth Potential

  • The planned use of IPO proceeds for automation and new manufacturing capacity may support expansion of production capabilities and wider client engagement over time.

  • The company’s presence across ayurvedic and nutraceutical segments, along with domestic and export markets, provides scope to cater to varied healthcare manufacturing requirements as demand for such products continues to evolve.

Key Performance Indicator (KPI)

KPI

Mar 31, 2025

ROE

81.22%

ROCE

36.98%

Debt/Equity

0.72

RoNW

48.85%

PAT Margin

16.33%

EBITDA Margin

22.79%

Price to Book Value

8.76

Accretion Nutraveda Limited IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

Kfin Technologies Ltd.

Sobhagya Capital Options Pvt.Ltd.

Company Address of Accretion Nutraveda Limited

Accretion Nutraveda Ltd. 27 Xcelon Industrial Park-1 Vasna-Chacharwadi, TaSanand, Ahmedabad, Gujarat, 382213

Phone: +91- 9904366177

Email: compliance@accretionnutraveda.com

Website: https://accretionnutraveda.com/

Conclusion

Accretion Nutraveda Limited operates as a contract manufacturer in the ayurvedic and nutraceutical segments, with a product portfolio covering multiple healthcare categories and manufacturing activities supported by recognised certifications. The IPO outlines defined objectives related to capacity expansion, automation, and working capital requirements, as disclosed in the offer details.

The IPO application process follows a standard online route through ASBA or supported trading platforms and requires a Demat account with a linked bank account. Investors may review the issue schedule, pricing, allocation structure, and disclosed risks before submitting an application within the specified timeline.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Accretion Nutraveda IPO allotment status.     

Frequently Asked Questions

No result found

search icon
Published Date : 27 Jan 2026

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

11 lakh+ Users

icon-with-text

4.8 App Rating

icon-with-text

4 Languages

icon-with-text

₹7,900+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|